IL144289A0 - Functionalized heterocycles as chemokine receptor modulators - Google Patents

Functionalized heterocycles as chemokine receptor modulators

Info

Publication number
IL144289A0
IL144289A0 IL14428999A IL14428999A IL144289A0 IL 144289 A0 IL144289 A0 IL 144289A0 IL 14428999 A IL14428999 A IL 14428999A IL 14428999 A IL14428999 A IL 14428999A IL 144289 A0 IL144289 A0 IL 144289A0
Authority
IL
Israel
Prior art keywords
chemokine receptor
receptor modulators
functionalized heterocycles
heterocycles
functionalized
Prior art date
Application number
IL14428999A
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of IL144289A0 publication Critical patent/IL144289A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
IL14428999A 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators IL144289A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11565499P 1999-01-13 1999-01-13
PCT/US1999/030434 WO2000042045A2 (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators

Publications (1)

Publication Number Publication Date
IL144289A0 true IL144289A0 (en) 2002-05-23

Family

ID=22362668

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14428999A IL144289A0 (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators

Country Status (20)

Country Link
EP (1) EP1144415A2 (en)
JP (1) JP2002534526A (en)
KR (1) KR20010086166A (en)
CN (1) CN1344270A (en)
AP (1) AP2001002228A0 (en)
AU (1) AU1940900A (en)
BR (1) BR9916905A (en)
CA (1) CA2372197A1 (en)
CZ (1) CZ20012502A3 (en)
EA (1) EA200100774A1 (en)
HK (1) HK1044539A1 (en)
HU (1) HUP0202932A3 (en)
IL (1) IL144289A0 (en)
MX (1) MXPA01007033A (en)
NO (1) NO20013456L (en)
OA (1) OA11820A (en)
PL (1) PL349348A1 (en)
SK (1) SK9972001A3 (en)
WO (1) WO2000042045A2 (en)
ZA (1) ZA200106592B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951848B2 (en) 2001-03-12 2005-10-04 Millennium Pharmaceuticals, Inc., Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
HU230322B1 (en) 2001-03-29 2016-01-28 Eli Lilly And Co. N-(2-arylethyl)-benzylamines as antagonists of the 5-ht6 receptor and pharmaceutical compositions containing them
WO2003035650A1 (en) * 2001-09-25 2003-05-01 Takeda Chemical Industries, Ltd. Entry inhibitor
TWI344955B (en) 2003-03-14 2011-07-11 Ono Pharmaceutical Co Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
US7498323B2 (en) 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
PE20060598A1 (en) 2004-09-13 2006-08-21 Ono Pharmaceutical Co HETEROCYCLE DERIVATIVE CONTAINING NITROGEN AS ANTAGONIST OF CCR5 CHEMOKINE
EP1889622A4 (en) 2005-05-31 2009-12-23 Ono Pharmaceutical Co Spiropiperidine compound and medicinal use thereof
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007049771A1 (en) 2005-10-28 2007-05-03 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
ES2407115T3 (en) 2005-11-18 2013-06-11 Ono Pharmaceutical Co., Ltd. Compound containing a basic group and its use
CN101460458A (en) 2006-02-15 2009-06-17 阿勒根公司 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
EP1984334B1 (en) * 2006-02-15 2014-04-09 Allergan, Inc. Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
EP1995246A4 (en) 2006-03-10 2010-11-17 Ono Pharmaceutical Co Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
JP5257068B2 (en) 2006-05-16 2013-08-07 小野薬品工業株式会社 Compound containing acidic group which may be protected and use thereof
WO2007136300A2 (en) * 2006-05-23 2007-11-29 Alla Chem, Llc Substituted indoles and a method for the production and use thereof
US20090325992A1 (en) 2006-07-31 2009-12-31 Ono Pharmaceutical Co., Ltd. Compound having cyclic group bound thereto through spiro binding and use thereof
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
JP2010515750A (en) * 2007-01-11 2010-05-13 アラーガン インコーポレイテッド 6-Substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
CA2799154A1 (en) 2010-05-12 2011-11-17 Abbvie Inc. Indazole inhibitors of kinase
US20140271680A1 (en) 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
JO3459B1 (en) 2012-09-09 2020-07-05 H Lundbeck As Pharmaceutical compositions for treating alzheimer's disease
CN104193669B (en) * 2014-08-01 2016-12-07 大连理工大学 One class Abiduoer analog or its salt, its preparation method and application
WO2016112088A1 (en) * 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
CN110256324A (en) * 2019-06-13 2019-09-20 苏州莱安医药化学技术有限公司 A kind of preparation method of 2- methyl -5-OHi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
US3518258A (en) * 1967-05-09 1970-06-30 Warner Lambert Pharmaceutical Pyrano(3,2-i)quinolizine and process for the production
US3565903A (en) * 1967-11-24 1971-02-23 Warner Lambert Pharmaceutical Pyrano(2,3-b)quinolines and process for their production
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
AU745687B2 (en) * 1997-02-26 2002-03-28 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCR1 receptor
JP2002501898A (en) * 1998-02-02 2002-01-22 メルク エンド カムパニー インコーポレーテッド Cyclic amine modulators of chemokine receptor activity

Also Published As

Publication number Publication date
KR20010086166A (en) 2001-09-08
CA2372197A1 (en) 2000-07-20
CZ20012502A3 (en) 2002-03-13
OA11820A (en) 2005-08-17
MXPA01007033A (en) 2003-07-21
HK1044539A1 (en) 2002-10-25
NO20013456D0 (en) 2001-07-12
HUP0202932A2 (en) 2002-12-28
JP2002534526A (en) 2002-10-15
EA200100774A1 (en) 2002-02-28
NO20013456L (en) 2001-09-12
PL349348A1 (en) 2002-07-15
WO2000042045A2 (en) 2000-07-20
AP2001002228A0 (en) 2001-09-30
AU1940900A (en) 2000-08-01
ZA200106592B (en) 2002-08-12
SK9972001A3 (en) 2002-03-05
EP1144415A2 (en) 2001-10-17
HUP0202932A3 (en) 2003-07-28
BR9916905A (en) 2002-01-29
WO2000042045A3 (en) 2000-11-09
CN1344270A (en) 2002-04-10

Similar Documents

Publication Publication Date Title
PL349348A1 (en) Functionalized heterocycles as chemokine receptor modulators
HK1043985A1 (en) Chemokine receptor binding heterocyclic compounds
EG25606A (en) Glucocorticoid receptor modulators
ZA200203181B (en) Positive modulators of nicotinic receptor agonists.
IL150059A0 (en) Novel heterocycles
ZA200203171B (en) Positive modulators of nicotinic receptor agonists.
GB9903767D0 (en) Receptor assay
IL146151A0 (en) Human-g-protein receptor
IL150200A0 (en) Substituted pyrroles
GB9927905D0 (en) Encoder device
GC0000265A (en) Substituted pyrroles
MXPA01011286A (en) Cyclocarbamate derivatives as progesterone receptor modulators.
PL350603A1 (en) Stopper
AU5572500A (en) Vegf receptor antagonists
AU2927800A (en) Signalling device
AUPQ451599A0 (en) Signalling device
GB0028305D0 (en) Liquid application means
PL110283U1 (en) Interphone
GB9922009D0 (en) CCR5 Modulators
GB9922702D0 (en) CCR5 modulators
AU2512800A (en) Alpha1-adrenergic receptor antagonists
PL359523A1 (en) Chemokine receptor binding heterocyclic compounds
TW444989U (en) Improved structure for handsfree device
GB9930392D0 (en) Substances
GB9923910D0 (en) Prolactin receptor